| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/15/2004 | US20040137614 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 07/15/2004 | US20040137592 Comprises phosphatidyl inositol kinase related protein for use in the identification of modulators for treatment of cystic fibrosis and/or muscular disorders |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137556 Yeast strains autonomously producing steroids |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137095 Phytochemotherapy for cancer |
| 07/15/2004 | US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 07/15/2004 | US20040137071 Nanocapsule encapsulation system and method |
| 07/15/2004 | US20040137014 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/15/2004 | US20040137009 DNA encoding a derivative of a human interferon- alpha selected from DNA encoding a protein in which one or more amino acid residues of the protein encoded by the above DNA have been replaced, deleted, and/or added |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 07/15/2004 | US20040136983 as anti-tumor agent or treating excessive vascular permeability; agonist for treating trauma to vascular network |
| 07/15/2004 | US20040136982 Novel monoclonal antibody |
| 07/15/2004 | US20040136962 Ordered molecular presetation of antigens, method of preparation and use |
| 07/15/2004 | US20040136949 Combination therapy using anti-angiogenic agents and tnf alpha |
| 07/15/2004 | US20040136908 Anti-cd19 immunotoxins |
| 07/15/2004 | DE10300049A1 Neue Verbindungen, die Faktor VIIa inhibieren Novel compounds which inhibit factor VIIa |
| 07/15/2004 | CA2551576A1 Tumour-inhibiting annellated azepinone derivatives |
| 07/15/2004 | CA2511612A1 Uses of interleukin-18 for treating skin disorders associated with uv radiations |
| 07/15/2004 | CA2511522A1 Novel proteins and use thereof |
| 07/15/2004 | CA2511506A1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 07/15/2004 | CA2511436A1 Centrosome-associated protein and applications thereof |
| 07/15/2004 | CA2511013A1 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | CA2510375A1 Aryl / hetaryl substituted imidazoquinolines |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | CA2508921A1 Quinazoline compounds |
| 07/15/2004 | CA2508917A1 Therapeutic agents |
| 07/15/2004 | CA2507699A1 Heteroarylalkanoic acids as integrin receptor antagonists |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1437352A1 Benzimidazole compound, process for producing the same, and use thereof |
| 07/14/2004 | EP1437349A1 Substituted isoxazoles and the use thereof as antibiotics |
| 07/14/2004 | EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity |
| 07/14/2004 | EP1437142A1 Cell growth inhibitors |
| 07/14/2004 | EP1437139A2 Method for protection against genotoxic mutagenesis |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436623A1 Modulation of tor |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436413A2 Response of dendritic cells to a diverse set of pathogens |
| 07/14/2004 | EP1436403A2 Use of the adenoviral e2 late promoter |
| 07/14/2004 | EP1436395A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436382A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 07/14/2004 | EP1436329A1 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436313A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/14/2004 | EP1436298A1 Himbacine analogues as thrombin receptor antagonists |
| 07/14/2004 | EP1436293A1 Polycyclic compounds having anti-tumor activity |
| 07/14/2004 | EP1436291A2 Indolizines as kinase protein inhibitors |
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436281A1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/14/2004 | EP1436279A1 Chemical compounds |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436266A2 Methods and compositions of novel triazine compounds |
| 07/14/2004 | EP1436259A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors |
| 07/14/2004 | EP1436258A2 Ph-dependent nmda receptor antagonists |
| 07/14/2004 | EP1436257A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1436246A1 Oligoamine compounds and derivatives thereof for cancer therapy |
| 07/14/2004 | EP1436011A2 Dendrimers for use in targeted delivery |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1436000A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 07/14/2004 | EP1435996A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435992A2 Chemokines as adjuvants of immune response |
| 07/14/2004 | EP1435991A1 Use of aplidine for the treatment of pancreatic cancer |
| 07/14/2004 | EP1435990A1 Kahalalide compounds for use in cancer therapy |
| 07/14/2004 | EP1435988A1 Improved use of antitumoral compound in cancer therapy |
| 07/14/2004 | EP1435986A2 Igf-binding protein-derived peptide or small molecule |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435984A1 Use of histamine to treat liver disease |
| 07/14/2004 | EP1435981A2 Anti-tumor activity from reptile serum |
| 07/14/2004 | EP1435965A2 Pharmaceutical compositions and methods for treating cancer |
| 07/14/2004 | EP1435963A2 Reduced toxicity cisplatin formulations and methods for using the same |
| 07/14/2004 | EP1435959A2 Inhibitors of the egf receptor for the treatment of thyroid cancer |
| 07/14/2004 | EP1435958A1 Use of phosphorodiesterase iv inhibitors |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435947A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435941A2 Wortmannin analogs and methods of using same |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |